AYA. F. Yusupov

A. F. Yusupov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


A. F. Yusupov has a total of 41 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Systemic inflammation indices in chronic kidney disease: clinical significance and prognostic aspects

    by I. T. Murkamilov, K. A. Aitbaev, V. V. Fomin, Zh. A. Murkamilova, Z. R. Raimzhanov, Sh. Sh. Khakimov, J. I. Solizhonov, A. F. Yusupov, T. F. Yusupova, Z. F. Yusupova, et al.

    THE AIM: to investigate systemic inflammation indices and their association with risk factors for cardiovascular complications in patients with chronic kidney disease (CKD). PATIENTS AND METHODS. The study included 744 patients (454 men and 290 women) with CKD at predialysis stages; the mean age was 38.3 ± 13.0 years. Patients were divided into two groups: Group 1 – CKD with subnephrotic proteinuria (3.5 g/day, n = 266). All patients underwent peripheral blood and biochemical analyses with the calculation of systemic inflammation indices. RESULTS. In the group of patients with CKD and nephrotic proteinuria, leukocyte count, erythrocyte sedimentation rate, and plasma fibrinogen concentration were significantly higher than in patients with CKD and subnephrotic proteinuria. The platelet-to-lymphocyte ratio (PLR) was higher in patients with CKD and nephrotic proteinuria (8.92 ± 3.39 vs 8.12 ± 2.20, p = 0.001), whereas the lymphocyte-to-C-reactive protein ratio (L/C-RP) was higher in patients with CKD and subnephrotic proteinuria (0.833 [0.167; 2.583] vs 0.323 [0.156; 1.917], p = 0.031). Correlation analysis showed that leukocyte count was positively associated with heart rate (r = 0.264; p < 0.05), total cholesterol (r = 0.119; p < 0.05), and daily proteinuria (r = 0.097; p < 0.05); lymphocyte count correlated with diastolic blood pressure (r = 0.214; p < 0.05); PLR correlated with heart rate (r = 0.376; p < 0.05) and LDL cholesterol (r = 0.374; p < 0.05); LDL cholesterol correlated negatively with L/M (r = –0.253; p < 0.05) and M/L (r = 0.287; p < 0.05). Estimated glomerular filtration rate (eGFR) correlated with L/C-RP (r = 0.300; p < 0.05), systemic inflammation response index (SIRI, r = –0.079; p < 0.05), and neutrophil-to-lymphocyte ratio (NLR, r = –0.077; p < 0.05). A negatively correlation was found between L/C-RP and plasma fibrinogen levels (r = –0.267; p < 0.05). CONCLUSION. In patients with CKD and subnephrotic proteinuria, the lymphocyte-to-C-reactive protein ratio was higher, whereas the platelet-to-lymphocyte ratio was higher in those with CKD and nephrotic proteinuria. Systemic inflammation indices (L/CRP, SIRI, NLR) showed a strong correlation with glomerular filtration rate and were independently associated with the risk of renal function decline and cardiovascular complications.

  • Remodeling of the major arteries of the brain and serum cystatin C levels in patients with non-communicable diseases

    by I.T. Murkamilov, K.A. Aitbaev, V.V. Fomin, Zh.A. Murkamilova, V.P. Mikhin, A.F. Yusupov, T.F. Yusupova, F.A. Yusupov

    Objective. To evaluate serum cystatin C concentrations and the remodeling of major arteries in patients with non-communicable diseases (NCDs). Material and methods. A total of 460 patients diagnosed with NCDs participated in the study, including 229 (49.8%) males and 231 (50.2%) females, with a mean age of 53.4±14.2 years. The subjects were categorized into three groups (1—3) based on serum cystatin C levels. Multiple laboratory, clinical, and instrumental parameters were assessed. Results. In individuals with NCDs, an increase in serum cystatin C from 1 mg/L to 3 mg/L correlated with an elevation in systolic blood pressure from 128±17 mmHg to 145±24 mmHg, and diastolic blood pressure from 84±10 mmHg to 87±12 mmHg. Additionally, total cholesterol levels rose from 4.68±1.00 mmol/L to 5.24±1.91 mmol/L, low-density lipoproteins increased from 3.15±0.88 mmol/L to 3.31±1.56 mmol/L, and triglycerides increased from 1.13 [0.89; 1.61] mmol/L to 1.59 [1.10; 2.45] mmol/L. Potassium levels increased from 4.35±0.61 mmol/L to 4.81±0.96 mmol/L, and creatinine levels rose from 67.3±13.1 μmol/L to 149.4 [102.8; 291.7] μmol/L. C-reactive protein levels rose from 7.8% to 22.8%, and fibrinogen levels increased from 3.0 [2.6; 3.7] g/L to 4.4 [3.3; 5.7] g/L, while urinary protein excretion increased from 423 [0; 100] mg/L to 6722 [0; 1250] mg/L. The estimated glomerular filtration rate decreased from 101.1±15.9 mL/min/1.73 m2 to 44.0 [22.0; 61.0] mL/min/1.73 m2. The diameter of the ascending aorta also increased, from 2.96±0.36 cm to 3.22±0.31 cm, while the prevalence of aortic atherosclerosis rose from 50.0% to 81.3%. The thickness of the intima-media complex (IMC) of the common carotid artery (CCA) increased from 0.87±0.24 mm to 1.04±0.26 mm, and the diameter of the vertebral arteries expanded from 3.47±0.37 mm to 3.62±0.40 mm. A decline in high-density lipoproteins was observed, from 1.16±0.30 mmol/L to 1.09±0.31 mmol/L, and calcium levels decreased from 2.16±0.33 mmol/L to 2.01±0.37 mmol/L. In groups 2 and 3, localized thickening of the CCA IMC of 1.11—1.3 mm was identified in 39 (19.3%) and 22 (18.6%) subjects, respectively. Local thickening of CCA IMC exceeding 1.3 mm was identified in 35 (17.3%) and 21 (17.8%) patients in groups 2 and 3, respectively. Serum cystatin C levels were significantly correlated with the diameter of the ascending aorta (r=0.307; p<0.05), the diameter of the vertebral arteries (r=0.224; p<0.05), and the thickness of the CCA IMC (r=0.324; p<0.05). Conclusion. Measurement of serum cystatin C in patients with non-communicable diseases demonstrates promising diagnostic utility as a laboratory marker of arterial remodeling and reflects the cerebrovascular risk, correlating with the wall thickness of the major arteries of the brain.

  • Aneurysmal subarachnoid hemorrhage

    by F.A. Yusupov, A.A. Yuldashev, A.F. Yusupov

    Aneurysmal subarachnoid hemorrhage (SAH) is among the most critical acute cerebrovascular conditions, marked by high mortality rates, significant disability, and a considerable socio-economic burden. Women over 55 years of age, as well as individuals with arterial hypertension, hereditary predispositions, congenital vascular anomalies, and a history of smoking, are particularly susceptible. This article consolidates current data on the epidemiology, risk factors, pathogenesis, clinical presentation, and diagnosis of aneurysmal SAH. Special emphasis is placed on the mechanisms of early brain injury and delayed cerebral ischemia—two crucial factors influencing disease outcomes. Contemporary therapeutic strategies, including microsurgical clipping and endovascular embolization, are discussed in depth, addressing their indications, effectiveness, and associated risks. The significance of prompt diagnosis, specialized approaches, and patient management in neurovascular centers is highlighted. A systematic, multistage, and interdisciplinary strategy for managing patients with acute aneurysmal SAH is examined, demonstrating an approach that can enhance survival and improve functional outcomes while minimizing the risk of rebleeding and severe neurological deficits.

  • Clinical and functional characteristics of Parkinson’s disease in patients with chronic kidney disease

    by F.A. Yusupov, M.SH. Abdykadyrov, A.F. Yusupov

    Objective. To evaluate the clinical and functional characteristics of Parkinson’s disease in patients with and without concomitant chronic kidney disease (CKD) and to assess the impact of renal dysfunction on motor, cognitive, and non-motor symptoms. Material and methods. A cross-sectional study was conducted involving 62 patients diagnosed with idiopathic Parkinson’s disease at stages I—III. The test group comprised 31 patients with an estimated glomerular filtration rate (eGFR) of 30—59 mL/min/1.73 m², while the control group comprised 31 patients with an eGFR of 60 mL/min/1.73 m² or higher. Various assessments were performed, including the Movement Disorder Society Unified Parkinson’s Disease Rating Scale (MDS-UPDRS), Hoehn and Yahr Scale, Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), and evaluations for depression, anxiety, and orthostatic dysfunction. Results. Demographic factors such as age, sex, and duration of Parkinson’s disease were similar between the groups; however, patients with CKD had a higher Hoehn and Yahr score (2.5 vs. 2.0; p<0.05). Although the levodopa equivalent dose was greater in this cohort, the difference was not statistically significant. With an equal duration of the disease, motor impairments were more severe in the CKD group, with MDS-UPDRS III scores of 42.8±8.5 compared to 34.6±7.2 in the control group (p<0.001). In patients with CKD, axial symptoms, including gait disturbances, postural instability, and bradykinesia, were more prominent, while resting tremor was less evident. Cognitive function assessments revealed a decline in performance in patients with CKD: MMSE scores averaged 24.8±2.1, compared with 26.5±1.8 in the control group (p<0.05), and MoCA scores averaged 20.6±3.4, compared with 25.4±2.2 (p<0.001), respectively. Among the CKD patients, 83.8% exhibited mild cognitive impairment (MoCA< 26), contrasting with 38.7% in the control group. Specifically, executive, visual-spatial, attention, and memory functions were significantly impacted. A positive correlation was found between eGFR and total MoCA scores (rS=0.48; p=0.005). Furthermore, non-motor manifestations were more common in the CKD group, with rates of depression at 64.5% vs. 38.7%, anxiety at 58.1% vs. 32.2%, constipation at 74.2% vs. 51.6%, daytime sleepiness at 54.8% vs. 25.8%, and orthostatic hypotension at 38.7% vs. 19.4% (p<0.05). Conclusions. The presence of CKD is associated with a more severe motor and cognitive phenotype in Parkinson’s disease, predominantly characterized by axial dysfunction and diminished executive functions. These findings highlight the importance of assessing renal function when evaluating the progression of Parkinson’s disease.

  • Hyperuricemia and the cardio-reno-metabolic continuum in chronic kidney disease

    by I. T. Murkamilov, K. A. Aitbaev, V. V. Fomin, Zh. A. Murkamilova, Z. R. Raimzhanov, Sh. Sh. Khakimov, I. U. Abdurakhmanov, J. I. Solizhonov, T. F. Yusupova, Z. F. Yusupova, et al.

    Objective. To investigate the relationship between serum uric acid levels and echocardiographic (EchoCG) parameters, and to assess the association of hyperuricemia with cardiovascular and renal abnormalities in patients with chronic kidney disease (CKD). Material and methods. A cross-sectional retrospective study included clinical, instrumental, laboratory, and EchoCG data from 473 patients (307 men and 166 women) with a confi rmed diagnosis of CKD. The mean age of the study participants was 38.5 ± 12.7 years. Hyperuricemia was defi ned as serum uric acid ≥ 0.42 mmol/L in men and ≥ 0.36 mmol/L in women. Patients were divided into subgroups: CKD with hyperuricemia (n = 199) and CKD without hyperuricemia (n = 274). Results. Among all patients with CKD (n = 473), hyperuricemia was observed in 199 cases (42.0%). Compared with patients without hyperuricemia, those with CKD and hyperuricemia had signifi cantly higher mean age, body mass index, systolic and diastolic blood pressure the size of cardiac structures according to ECHOCG data and serum creatinine levels were statistically significantly higher. In contrast, hemoglobin concentration, red blood cell count, and estimated glomerular fi ltration rate (eGFR) were significantly lower. Signifi cant correlations of serum uric acid were found with systolic and diastolic blood pressure, eGFR, left atrial anteroposterior diameter, left ventricular end-systolic and end-diastolic diameter, interventricular septum thickness, posterior wall thickness of the left ventricle, left ventricular ejection fraction, and venous blood glucose. Conclusion. The study demonstrated a signifi cant contribution of hyperuricemia to alterations in the geometry of the left heart chambers and a decline in renal filtration function.

  • Clinical characteristics of pain syndromes in dental practice among patients with chronic kidney disease

    by A.F. Yusupov, M.SH. Abdykadyrov, F.A. Yusupov

    The analysis of the etiology, pathogenesis and clinical features of the appearance of pain syndrome in the maxillofacial region in patients with chronic kidney disease is presented. The mechanisms of the effect of uremic intoxication on the oral mucosa and the peripheral nervous system are considered. Specific conditions such as uremic stomatitis, trigeminal neuropathy, and burning mouth syndrome have been identified. Special attention is paid to the manifestations of bone mineral disorders (CKD-MBD), including renal osteodystrophy of the jaws. The approach to pharmacological pain relief is systematized: a strict ban on the use of nonsteroidal anti-inflammatory drugs (NSAIDs) is justified and algorithms for the safe dosing of analgesics and adjuvants (gabapentinoids) are proposed, taking into account the reduced glomerular filtration rate and dialysis clearance. Clinical recommendations on dental treatment tactics, including hemostasis measures and timing of hemodialysis sessions to minimize the risks of complications, are also formulated.

  • Morphofunctional features of the left ventricle in patients with chronic cerebral ischemia

    by I.T. Murkamilov, K.A. Aitbaev, V.V. Fomin, Zh.A. Murkamilova, Z.R. Rayimzhanov, A.F. Yusupov, Z.F. Yusupova, T.F. Yusupova, F.A. Yusupov, K.A. Gassanov

    Objective. To study the features of left ventricle (LV) structural adjustment and comorbidity in patients with chronic cerebral ischemia (CCI) based on gender. Material and methods. The study included 316 patients diagnosed with chronic cerebral ischemia with a mean age of 61.9 years (range 36 to 86 years). All patients underwent a general clinical examination, assessment of echocardiography parameters, and measurement of the thickness of the common carotid artery (CCA) intima-media complex (IMC). The patients were divided into two groups based on gender: Group I included males (n=170), and Group II included females (n=146). Results. In males with CCI, the CCA IMC thickness (1.23±0.14 mm vs 1.16±0.11 mm, p<0.05) and the prevalence of atherosclerotic changes (57.6% vs 34.9%, p<0.05) were significantly higher than in females. Normal LV geometry was reported in 59.4% of males and only in 37.0% of females (p<0.05). The frequency of concentric LV remodeling was 8.8% in males and 6.2% in females. LV hypertrophy (LVH) was detected in 31.8% of males and 56.8% of females (p<0.05). The concentric type of LVH was more common in males (68.5%), whereas the eccentric type prevailed in females (74.7%). A statistically significant correlation of CCA IMC thickness with age (r=0.234), systolic (r=0.209) and diastolic blood pressure (r=0.151), hemoglobin concentration (r=–0.245), end-systolic LV size (r=0.125), end-systolic (r=0.151) and end-diastolic (r=0.135) LV volumes, as well as LV myocardial mass index (r=0.132) in the total sample was found. In the male group, CCA IMC thickness correlated with body mass index (r=0.291) and diastolic blood pressure (r=0.210). In the female group, strong correlations were found with hemoglobin concentration (r=–0.732) and end-systolic LV volume (r=0.176). Conclusion. In patients with CCI, the most common morphofunctional LV changes were concentric LVH in males and eccentric LVH in females.


  • Open Access

    Geometry of the left ventricle and structure of the common carotid artery in persons with chronic non-infectious diseases

    by И. Т. Муркамилов, I. S. Sabirov, Zh. A. Murkamilova, V. V. Fomin, Sh. Sh. Khakimov, А. F. Yusupov, Z. F. Yusupova, T. F. Yusupova, F. А. Yusupov, Э. Ф. Юсупова

    Aim of study. To analyze the state of the left ventricular geometry and structural features of the common carotid artery in men and women with chronic noncommunicable diseases. Material and methods. Clinical and instrumental data of 475 patients with chronic non-communicable diseases were used. The average age of the participants was 52.3±13.4 years, all patients underwent general clinical examination. The frequency of various structural changes in the left ventricular (LV) myocardium and the intima-media thickness of the common carotid artery (CCA) were analyzed. Patients were divided into subgroups of men (n=237) and women (n=238). Results. In the examined men, the levels of creatinine, cystatin C, and the LV myocardial mass index were significantly higher, while the glomerular filtration rate was significantly lower. In the subgroup of women, hemoglobin concentration and the number of erythrocytes were significantly lower, whereas the number of platelets was significantly higher. In individuals with chronic non-communicable diseases, structural LV changes were represented as follows: normal geometry (68.0%), concentric remodeling (6.1%), LV hypertrophy (25.8%), including concentric LVH (41.5%) and eccentric LVH (58.5%). Concentric remodeling was observed in 8.0% of men and 4.2% of women. The frequency of LVH was significantly higher in women (31.0%) compared to men (20.6%). Initial atherosclerotic changes were detected in 23.8% of patients, while atherosclerotic lesions of the CCA were found in 33.3%. In men, the frequency of CCA atherosclerotic lesions was significantly higher (41.3%) than in women (25.2%). In the subgroup of women with atherosclerotic lesions of the CCA, the incidence of LVH was significantly higher than in women without CCA lesions. Cystatin C positively correlated with the LV myocardial mass index (r=0.41143; pConclusion. Left ventricular hypertrophy, especially the eccentric type, is frequently detected in patients with chronic non-communicable diseases, predominantly in women. Structural changes of the CCA are significantly more often detected in men. As the intima-media thickness of the CCA increases, the incidence of LVH also increases. Cystatin C concentration is associated with structural changes in the LV myocardium and CCA.

  • Stroke risk associated with chronic kidney disease

    by F. A. Yusupov, A. F. Yusupov, A. A. Yuldashev

    Chronic kidney disease (CKD) is the most significant risk factor in the development of stroke; the latter remains the leading cause of morbidity and mortality globally. CKD patients, especially at the end-stage renal failure and on dialysis, have a very high risk of stroke by 5 – 30 times, with a mortality rate reaching almost 90%. CKD is associated with both ischemic and hemorrhagic stroke. In addition to general risk factors, increased cerebrovascular risk is due to several mechanisms associated with CKD, such as platelet dysfunction, blood clotting disorders, endothelial dysfunction, inflammation, and an increased risk of atrial fibrillation. In addition, CKD can significantly affect the effectiveness of stroke treatment and prevention. Therefore, it is important to study the factors contributing to the development of stroke in this vulnerable population group to apply preventive strategies more effectively. This article examines the epidemiology and pathophysiology of the association between CKD and stroke, as well as the impact of CKD on stroke outcomes. The study aimed to review scientific articles published over the past twenty years on the relationship between CKD and stroke risk. To achieve this objective, a search was used for the keywords «chronic kidney disease», «stroke», «risk», «stroke risk factors» in the databases PubMed, Google Scholar and eLibrary.


  • RNA Therapeutic Agents as a New Generation of Drugs for the Treatment of Cardiovascular Diseases

    by K. Aitbaev, I. Murkamilov, А. Yusupov, Z. Raimzhanov, Zh. Murkamilova, F. Yusupov, T. Yusupova, O. Zakirov, K. Khabibullaev, I. Abdibaliev

    RNA therapeutic agents represent a novel and promising class of drugs aimed at preventing and treating various diseases, including cardiovascular pathologies. These agents enable temporary regulation of target gene expression, opening new possibilities for therapy. Depending on the approach, RNA-based drugs can replace, supplement, correct, or suppress gene expression. The main classes of RNA therapy include antisense oligonucleotides (ASOs), microRNAs (miRNAs), small interfering RNAs (siRNAs), RNA aptamers, and messenger RNAs (mRNAs). This article discusses existing challenges, such as drug delivery to target organs, as well as the advantages of RNA therapy, including cost-effectiveness, simplicity of production, and the ability to target hard-to-treat diseases. Additionally, the mechanisms of action of various RNA-based drugs and their impact on gene expression are thoroughly reviewed. Particular attention is given to clinical trials and the efficacy of drugs that have already received regulatory approval.